Lawson Macartney's most recent trade in Viking Therapeutics Inc was a trade of 20,400 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Viking Therapeutics Inc | Lawson Macartney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 20,400 | 20,400 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Lawson Macartney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 3,150 | 51,115 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Viking Therapeutics Inc | Lawson Macartney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 18,800 | 18,800 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Lawson Macartney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 2,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Lawson Macartney | Director | Sale of securities on an exchange or to another person at price $ 68.67 per share. | 08 Nov 2024 | 2,000 | 47,965 (0%) | 0% | 68.7 | 137,333 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Lawson Macartney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.80 per share. | 08 Nov 2024 | 2,000 | 49,965 (0%) | 0% | 5.8 | 11,600 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Lawson Macartney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 32,000 | 32,000 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Lawson Macartney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2023 | 16,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Lawson Macartney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.19 per share. | 16 May 2023 | 16,000 | 63,965 (0%) | 0% | 1.2 | 19,040 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Lawson Macartney | Director | Sale of securities on an exchange or to another person at price $ 24.00 per share. | 16 May 2023 | 16,000 | 47,965 (0%) | 0% | 24 | 384,000 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Lawson Macartney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2023 | 16,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Lawson Macartney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.33 per share. | 24 Apr 2023 | 16,000 | 63,965 (0%) | 0% | 3.3 | 53,280 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Lawson Macartney | Director | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 24 Apr 2023 | 16,000 | 47,965 (0%) | 0% | 22.0 | 352,061 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Lawson Macartney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 20,786 | 0 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Lawson Macartney | Director | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 17 Apr 2023 | 20,786 | 47,965 (0%) | 0% | 20 | 415,720 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Lawson Macartney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.00 per share. | 17 Apr 2023 | 20,786 | 68,751 (0%) | 0% | 8 | 166,288 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Lawson Macartney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Lawson Macartney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) |